Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis

The clinical outcomes of hepatocellular carcinoma (HCC) remain dismal. Elucidating the molecular mechanisms for the progression of aggressive HCC holds the promise for developing novel intervention strategies. The transactivation response element RNA-binding protein (TRBP/TARBP2), a key component of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li-Man, Chen, Chang, Ran, Ruo-Xi, Huang, Jing-Tao, Sun, Hui-Lung, Zeng, Chang, Zhang, Zhou, Zhang, Wei, Liu, Song-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265608/
https://www.ncbi.nlm.nih.gov/pubmed/34249676
http://dx.doi.org/10.3389/fonc.2021.620912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265608/
https://www.ncbi.nlm.nih.gov/pubmed/34249676
http://dx.doi.org/10.3389/fonc.2021.620912

Ejemplares similares